Dr. Reddys Labs (RDY) Reports Q3 EPS of $0.53

Dr. Reddys Labs (NYSE: RDY) reported Q3 EPS of $0.53, versus $0.67 reported last year. Revenue for the quarter came in at $610 million, versus $561 million reported last year.

For earnings history and earnings-related data on Dr. Reddys Labs (RDY) click here.

You May Also Be Interested In

• Klarna shares tumble on weak full-year revenue guidance
• Airgain wins two IoT modem deals for AI data center power systems
• The free USDA tool that tracks egg prices at $0.62/dozen before your data vendor does